CCCC
Price
$3.06
Change
-$0.12 (-3.77%)
Updated
Oct 23 closing price
Capitalization
376.46M
11 days until earnings call
Intraday BUY SELL Signals
MGTX
Price
$9.21
Change
-$0.56 (-5.73%)
Updated
Oct 23 closing price
Capitalization
884.56M
18 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs MGTX

CCCC vs MGTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CCCC vs. MGTX commentary
Oct 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and MGTX is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CCCC with price predictions
Oct 23, 2026

CCCC's RSI Oscillator ascends from oversold territory

The RSI Indicator for CCCC moved out of oversold territory on October 08, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 41 similar instances when the indicator left oversold territory. In 35 of the 41 cases the stock moved higher. This puts the odds of a move higher at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CCCC just turned positive on October 19, 2026. Looking at past instances where CCCC's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.

Following a +0.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCCC advanced for three days, in 196 of 238 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

CCCC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CCCC as a result. In 82 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCCC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for CCCC entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.522) is normal, around the industry mean (3.035). P/E Ratio (-3.363) is within average values for comparable stocks, (-1.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (10.989) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. CCCC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCCC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for MGTX with price predictions
Oct 23, 2026

MGTX's RSI Oscillator ascending out of oversold territory

The RSI Indicator for MGTX moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In 23 of the 25 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for MGTX just turned positive on October 21, 2026. Looking at past instances where MGTX's MACD turned positive, the stock continued to rise in 33 of 40 cases over the following month. The odds of a continued upward trend are 82%.

Following a +7.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where MGTX advanced for three days, in 212 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

MGTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

MGTX moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MGTX crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for MGTX entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 16 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. MGTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 70 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.103) is normal, around the industry mean (3.035). P/E Ratio (10.348) is within average values for comparable stocks, (-1.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (2.715) is also within normal values, averaging (438.009).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MGTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
CCCC vs MGTX: Fundamental Ratings
CCCC
MGTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9816
PRICE GROWTH RATING
1..100
5063
P/E GROWTH RATING
1..100
2470
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CCCC's Valuation (29) in the null industry is somewhat better than the same rating for MGTX (84) in the Biotechnology industry. This means that CCCC’s stock grew somewhat faster than MGTX’s over the last 12 months.

CCCC's Profit vs Risk Rating (100) in the null industry is in the same range as MGTX (100) in the Biotechnology industry. This means that CCCC’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's SMR Rating (16) in the Biotechnology industry is significantly better than the same rating for CCCC (98) in the null industry. This means that MGTX’s stock grew significantly faster than CCCC’s over the last 12 months.

CCCC's Price Growth Rating (50) in the null industry is in the same range as MGTX (63) in the Biotechnology industry. This means that CCCC’s stock grew similarly to MGTX’s over the last 12 months.

CCCC's P/E Growth Rating (24) in the null industry is somewhat better than the same rating for MGTX (70) in the Biotechnology industry. This means that CCCC’s stock grew somewhat faster than MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CCCCMGTX
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
COMPARISON
Comparison
Oct 25, 2026
Stock price -- (CCCC: $3.06 vs. MGTX: $9.21)
Brand notoriety: CCCC and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 264% vs. MGTX: 70%
Market capitalization -- CCCC: $376.46M vs. MGTX: $884.56M
CCCC [@Biotechnology] is valued at $376.46M. MGTX’s [@Biotechnology] market capitalization is $884.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.8B. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 2 FA rating(s) are green while MGTX’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 2 green, 3 red.
  • MGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, CCCC is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while MGTX’s TA Score has 5 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 4 bearish.
  • MGTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а +10.67% price change this week, while MGTX (@Biotechnology) price change was -0.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was -16.30%, and the average quarterly price growth was -16.78%.

Reported Earning Dates

CCCC is expected to report earnings on Nov 05, 2026.

MGTX is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CCCC
Daily Signal:
Gain/Loss:
MGTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
KDA.X0.0095190.000174
+1.87%
Kadena cryptocurrency
QKC.X0.0023940.000004
+0.17%
QuarkChain cryptocurrency
AION.X0.001907-0.000026
-1.34%
AION 5100 cryptocurrency
T.X0.004613-0.000087
-1.85%
Threshold cryptocurrency
STRK.X0.047007-0.002380
-4.82%
Starknet cryptocurrency

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with RCKT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-3.77%
RCKT - CCCC
43%
Loosely correlated
-0.87%
FDMT - CCCC
42%
Loosely correlated
-8.86%
SLDB - CCCC
42%
Loosely correlated
-4.36%
SVRA - CCCC
41%
Loosely correlated
-7.05%
CLDX - CCCC
41%
Loosely correlated
+0.97%
More